Laboratory of David R Fooksman, Ph.D.
The Fooksman laboratory is interested in various aspects of normal and malignant plasma cell physiology.  Plasma cells are terminally-differentiated B cells that secrete antibody, constitutively.  These cells are produced following vaccination or exposures to infection and produce antibody that specifically targets and neutralizes these foreign agents. Plasma cells can survive for decades in the body, particularly those that migrate to the bone marrow.   By surviving and producing antibody, these cells can provide long-term immune memory against secondary infections.  These cells are critical for healthy immune function and the essential end product for vaccines.  Therefore, we are interested in how these cells develop, migrate, survive and function.  

They can also become malignant in various diseases including cancer.  One notable example is in patients with Multiple Myeloma, a plasma cell tumor that also migrates to the bone marrow.  Currently, there are no cures for this cancer and treatments have strong side effects.  We would like to understand how the tumor spreads and interacts with the host environment to develop better treatments. 

In addition to using the modern toolkit of Immunology, we apply in vivo imaging to visualize and understand the cellular processes directly in the body. 


News

  • Two new papers! Two collaborative studies using our intravital imaging techniques are just out this Spring!  One was with Laura Santambrogio's lab to look at  changes in drainage and  trafficking  in lymphatics ...
    Posted Jun 10, 2015, 7:50 AM by David Fooksman
  • New Incubator Box, v2 We have installed a new light and temperature incubator on the two-photon microscope.  This was based on a prototype we built out of black foam posterboard using Thorlabs rails ...
    Posted Sep 3, 2014, 9:19 AM by David Fooksman
  • David awarded Sinsheimer Fund Award The lab received  the 2014 Alexandrine and Alexander L. Sinsheimer Fund Award  for three years!!
    Posted Aug 4, 2014, 11:35 AM by David Fooksman
Showing posts 1 - 3 of 10. View more »